Andrew Gesek
2019
In 2019, Andrew Gesek earned a total compensation of $604.9K as President, TIMM Medical at Petros Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $234,688 |
|---|---|
| Salary | $300,000 |
| Other | $70,250 |
| Total | $604,937 |
Gesek received $300K in salary, accounting for 50% of the total pay in 2019.
Gesek also received $234.7K in non-equity incentive plan and $70.3K in other compensation.
Rankings
In 2019, Andrew Gesek's compensation ranked 11,180th out of 13,971 executives tracked by ExecPay. In other words, Gesek earned more than 20.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,180 out of 13,971 | 20th |
Division Manufacturing | 4,519 out of 5,695 | 21st |
Major group Chemicals And Allied Products | 1,772 out of 2,194 | 19th |
Industry group Drugs | 1,525 out of 1,880 | 19th |
Industry Pharmaceutical Preparations | 1,126 out of 1,392 | 19th |
Source: SEC filing on November 22, 2021.
Gesek's colleagues
We found three more compensation records of executives who worked with Andrew Gesek at Petros Pharmaceuticals in 2019.
News
Petros Pharmaceuticals President and Chief Commercial Officer Fady Boctor's 2022 pay falls 42% to $682K
August 25, 2023
Petros Pharmaceuticals President and Chief Commercial Officer Fady Boctor's 2021 pay jumps 152% to $1.2M
October 12, 2022
Petros Pharmaceuticals President and Chief Commercial Officer Fady Boctor's 2020 pay jumps 38% to $468K
November 22, 2021